Olaratumab

Olaratumab is a prescription medicine used to treat adults with a certain type of soft tissue sarcoma (a type of cancer that affects the body's connective tissues). It is given in combination with the chemotherapy medicine doxorubicin. Olaratumab works by blocking the action of a protein called platelet-derived growth factor receptor alpha (PDGFR-α), which helps cancer cells survive and grow.

Olaratumab, also commercially available under the brand name Lartruvo, is a medication used in conjunction with other therapies for specific types of cancer. Here's a detailed description of its characteristics:

Function:

• Anti-PDGFRα antibody: Olaratumab belongs to a class of drugs known as monoclonal antibodies. These are laboratory-produced proteins designed to target specific structures or cells. In this case, Olaratumab acts against a protein called platelet-derived growth factor receptor alpha (PDGFRα).

Applications:

• Gastrointestinal Stromal Tumors (GISTs): Olaratumab is primarily indicated for the treatment of advanced GISTs. These are rare tumors that develop in the digestive system, often in the stomach or intestines.
• Combined therapy: It's not used alone but rather administered in combination with another medication called regorafenib. This combination therapy is intended for patients with GISTs that have either not responded adequately to initial treatment (first-line therapy) or whose cancer has recurred (relapsed) after prior treatment.

Mechanism of Action:

• Blocks PDGFRα signaling: PDGFRα plays a crucial role in the growth and development of certain cells, including some cancer cells. Olaratumab binds to PDGFRα, blocking its signaling pathway and thereby hindering the growth and spread of tumor cells.

Important Considerations:

• Prescription medication: Olaratumab is a powerful drug and should only be administered under the strict supervision of a qualified oncologist specializing in cancer treatment.
• Combination therapy: As mentioned earlier, it's always used in combination with regorafenib.
• Not a first-line treatment: Olaratumab is typically reserved for situations where other treatment options have failed.
• Potential side effects: Like any medication, Olaratumab can cause various side effects, including:
  • Fatigue
  • High blood pressure
  • Headache
  • Diarrhea
  • Rash
  • Mouth sores
  • Bleeding events (increased risk in some cases)